Pre-treatment evaluation of LVEF for breast cancer patients receiving anthracyclines: Is it necessary?
Peddi, Prakash, Master, Samip R., Ravipati, Hari P, Patel, Abhishek H, Dwary, Ashish Dutta, Pasam, Avinash, Chu, Quyen, Shi, Runhua, Burton, Gary Von
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines
Peddi, Prakash, Master, Samip R., Dwary, Ashish D., Ravipati, Hari P., Patel, Abhishek H., Pasam, Avinash, Katikaneni, Pavan K., Shi, Runhua, Burton, Gary V., Chu, Quyen D.
Published in The breast journal (01.01.2019)
Published in The breast journal (01.01.2019)
Get full text
Journal Article
Impact of race and payer status on the outcome of chronic myeloid leukemia (CML) in the era of tyrosine kinase inhibitors
Devarakonda, Srinivas S., Pasam, Avinash, Comeau, Jill, Nair, Binu Sivaraman, Munker, Reinhold, Burton, Gary Von, Mills, Glenn Morris, Koshy, Nebu V.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article